Inhibition of hsp90 compromises the DNA damage response to radiation - PubMed (original) (raw)
Inhibition of hsp90 compromises the DNA damage response to radiation
Hideaki Dote et al. Cancer Res. 2006.
Abstract
Inhibitors of the molecular chaperone Hsp90 have been shown to enhance tumor cell radiosensitivity. To begin to address the mechanism responsible, we have determined the effect of the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17DMAG) on the DNA damage response to radiation. Exposure of MiaPaCa tumor cells to 17DMAG, which results in radiosensitization, inhibited the repair of DNA double-strand breaks according to gammaH2AX foci dispersal and the neutral comet assay. This repair inhibition was associated with reduced DNA-PK catalytic subunit (DNA-PKcs) phosphorylation after irradiation and a disruption of DNA-PKcs/ErbB1 interaction. These data suggest that the previously established 17DMAG-mediated reduction in ErbB1 activity reduces its interaction with DNA-PKcs and thus accounts for the attenuation of radiation-induced DNA-PK activation. 17DMAG was also found to abrogate the activation of the G(2)- and S-phase cell cycle checkpoints. Associated with these events was a reduction in radiation-induced ataxia-telangiectasia mutated (ATM) activation and foci formation in 17DMAG-treated cells. Although no interaction between ATM and Hsp90 was detected, Hsp90 was found to interact with the MRE11/Rad50/NBS1 (MRN) complex. 17DMAG exposure reduced the ability of the MRN components to form nuclear foci after irradiation. Moreover, 17DMAG exposure reduced the interaction between NBS1 and ATM, although no degradation of the MRN complex was detected. These results suggest that the diminished radiation-induced activation of ATM in 17DMAG-treated cells was the result of a compromise in the function of the MRN complex. These data indicate that Hsp90 can contribute to the DNA damage response to radiation affecting both DNA repair and cell cycle checkpoint activation.
Similar articles
- ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
Dote H, Cerna D, Burgan WE, Camphausen K, Tofilon PJ. Dote H, et al. Cancer Res. 2005 Aug 1;65(15):6967-75. doi: 10.1158/0008-5472.CAN-05-1304. Cancer Res. 2005. PMID: 16061682 - Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V, Sausville EA, Camalier RF, Fiebig HH, Burger AM. Smith V, et al. Cancer Chemother Pharmacol. 2005 Aug;56(2):126-37. doi: 10.1007/s00280-004-0947-2. Epub 2005 Apr 20. Cancer Chemother Pharmacol. 2005. PMID: 15841378 - Inhibition of Hsp90: a multitarget approach to radiosensitization.
Camphausen K, Tofilon PJ. Camphausen K, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4326-30. doi: 10.1158/1078-0432.CCR-07-0632. Clin Cancer Res. 2007. PMID: 17671112 Review. - 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities.
Florczak U, Toulany M, Kehlbach R, Peter Rodemann H. Florczak U, et al. Radiother Oncol. 2009 Sep;92(3):334-8. doi: 10.1016/j.radonc.2009.06.005. Epub 2009 Jul 7. Radiother Oncol. 2009. PMID: 19589609 - Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
Yang SH, Kuo TC, Wu H, Guo JC, Hsu C, Hsu CH, Tien YW, Yeh KH, Cheng AL, Kuo SH. Yang SH, et al. World J Gastroenterol. 2016 Aug 28;22(32):7275-88. doi: 10.3748/wjg.v22.i32.7275. World J Gastroenterol. 2016. PMID: 27621574 Free PMC article. Review.
Cited by
- Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Raleigh DR, Haas-Kogan DA. Raleigh DR, et al. Future Oncol. 2013 Feb;9(2):219-33. doi: 10.2217/fon.12.185. Future Oncol. 2013. PMID: 23414472 Free PMC article. Review. - BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation.
Stecklein SR, Kumaraswamy E, Behbod F, Wang W, Chaguturu V, Harlan-Williams LM, Jensen RA. Stecklein SR, et al. Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13650-5. doi: 10.1073/pnas.1203326109. Epub 2012 Aug 6. Proc Natl Acad Sci U S A. 2012. PMID: 22869732 Free PMC article. - Mutations, protein homeostasis, and epigenetic control of genome integrity.
Xie JL, Jarosz DF. Xie JL, et al. DNA Repair (Amst). 2018 Nov;71:23-32. doi: 10.1016/j.dnarep.2018.08.004. Epub 2018 Aug 23. DNA Repair (Amst). 2018. PMID: 30181040 Free PMC article. Review. - Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922.
Tani T, Tojo N, Ohnishi K. Tani T, et al. Oncol Lett. 2022 Mar;23(3):102. doi: 10.3892/ol.2022.13222. Epub 2022 Jan 31. Oncol Lett. 2022. PMID: 35154433 Free PMC article. - Advances in DNA Repair-Emerging Players in the Arena of Eukaryotic DNA Repair.
Kciuk M, Bukowski K, Marciniak B, Kontek R. Kciuk M, et al. Int J Mol Sci. 2020 May 30;21(11):3934. doi: 10.3390/ijms21113934. Int J Mol Sci. 2020. PMID: 32486270 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous